Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osterosarcoma

NCT03358628 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03358628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03358628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osterosarcoma
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2018
Completion date
January 31, 2025
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma